Mirae Asset Global ETFs Holdings
HRTX icon

Mirae Asset Global ETFs Holdings’s Heron Therapeutics HRTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4K Buy
73,585
+460
+0.6% +$369 ﹤0.01% 3091
2026
Q1 		$58.5K Buy
73,125
+1,756
+2% +$2.04K ﹤0.01% 2866
2025
Q4 		$92.8K Sell
71,369
-491
-0.7% -$606 ﹤0.01% 2713
2025
Q3 		$90.5K Sell
71,860
-11,896
-14% -$18.9K ﹤0.01% 2710
2025
Q2 		$173K Buy
83,756
+13,544
+19% +$27.7K ﹤0.01% 2357
2025
Q1 		$154K Buy
70,212
+2,964
+4% +$5.75K ﹤0.01% 2443
2024
Q4 		$103K Buy
67,248
+2,888
+4% +$4.68K ﹤0.01% 2683
2024
Q3 		$128K Buy
64,360
+2,599
+4% +$6.21K ﹤0.01% 2584
2024
Q2 		$215K Buy
+61,761
New +$190K ﹤0.01% 2209

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's HRTX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Heron Therapeutics (HRTX) stake by 0.63% in Q2 2026, buying an estimated $369 and bringing the position to 73,585 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3091.

Mirae Asset Global ETFs Holdings first reported a position in HRTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $215K in Q2 2024. 163 funds tracked by Wall St. Rank hold HRTX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 73,585 shares of Heron Therapeutics worth $31.4K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 460 Heron Therapeutics shares in Q2 2026, an estimated $369.
  • Heron Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #3091 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Heron Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Heron Therapeutics position peaked at $215K in Q2 2024.
  • 163 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.